Cocco Maxwell P, White Evan, Xiao Shujie, Hu Donglei, Mak Angel, Sleiman Patrick, Yang Mao, Bobbitt Kevin R, Gui Hongsheng, Levin Albert M, Hochstadt Samantha, Whitehouse Kyle, Rynkowski Dean, Barczak Andrea J, Abecasis Gonçalo, Blackwell Thomas W, Kang Hyun Min, Nickerson Deborah A, Germer Soren, Ding Jun, Lanfear David E, Gilliland Frank, Gauderman W James, Kumar Rajesh, Erle David J, Martinez Fernando, Hakonarson Hakon, Burchard Esteban G, Williams L Keoki
Center for Individualized and Genomic Medicine Research (CIGMA), Department of Internal Medicine, Henry Ford Health System, Detroit, Michigan, United States of America.
Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
PLoS One. 2020 Nov 25;15(11):e0242364. doi: 10.1371/journal.pone.0242364. eCollection 2020.
Mitochondria support critical cellular functions, such as energy production through oxidative phosphorylation, regulation of reactive oxygen species, apoptosis, and calcium homeostasis.
Given the heightened level of cellular activity in patients with asthma, we sought to determine whether mitochondrial DNA (mtDNA) copy number measured in peripheral blood differed between individuals with and without asthma.
Whole genome sequence data was generated as part of the Trans-Omics for Precision Medicine (TOPMed) Program on participants from the Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-ethnicity (SAPPHIRE) and the Study of African Americans, Asthma, Genes, & Environment II (SAGE II). We restricted our analysis to individuals who self-identified as African American (3,651 asthma cases and 1,344 controls). Mitochondrial copy number was estimated using the sequencing read depth ratio for the mitochondrial and nuclear genomes. Respiratory complex expression was assessed using RNA-sequencing.
Average mitochondrial copy number was significantly higher among individuals with asthma when compared with controls (SAPPHIRE: 218.60 vs. 200.47, P<0.001; SAGE II: 235.99 vs. 223.07, P<0.001). Asthma status was significantly associated with mitochondrial copy number after accounting for potential explanatory variables, such as participant age, sex, leukocyte counts, and mitochondrial haplogroup. Despite the consistent relationship between asthma status and mitochondrial copy number, the latter was not associated with time-to-exacerbation or patient-reported asthma control. Mitochondrial respiratory complex gene expression was disproportionately lower in individuals with asthma when compared with individuals without asthma and other protein-encoding genes.
We observed a robust association between asthma and higher mitochondrial copy number. Asthma having an effect on mitochondria function was also supported by lower respiratory complex gene expression in this group.
线粒体支持关键的细胞功能,如通过氧化磷酸化产生能量、调节活性氧、细胞凋亡和钙稳态。
鉴于哮喘患者细胞活性水平升高,我们试图确定外周血中测量的线粒体DNA(mtDNA)拷贝数在哮喘患者和非哮喘患者之间是否存在差异。
全基因组序列数据是精准医学跨组学计划(TOPMed)的一部分,该计划针对哮喘表型与种族药物基因组相互作用研究(SAPPHIRE)以及非裔美国人哮喘、基因与环境研究II(SAGE II)的参与者生成。我们将分析限制在自我认定为非裔美国人的个体(3651例哮喘病例和1344例对照)。使用线粒体和核基因组的测序读深度比估计线粒体拷贝数。使用RNA测序评估呼吸复合体表达。
与对照组相比,哮喘患者的平均线粒体拷贝数显著更高(SAPPHIRE:218.60对200.47,P<0.001;SAGE II:235.99对223.07,P<0.001)。在考虑潜在解释变量(如参与者年龄、性别、白细胞计数和线粒体单倍群)后,哮喘状态与线粒体拷贝数显著相关。尽管哮喘状态与线粒体拷贝数之间存在一致关系,但后者与病情加重时间或患者报告的哮喘控制无关。与非哮喘个体和其他蛋白质编码基因相比,哮喘个体的线粒体呼吸复合体基因表达不成比例地更低。
我们观察到哮喘与更高的线粒体拷贝数之间存在密切关联。该组中较低的呼吸复合体基因表达也支持哮喘对线粒体功能有影响。